DK2252609T3 - Pyridin-2-yl-derivater som immunomodulerende midler - Google Patents

Pyridin-2-yl-derivater som immunomodulerende midler

Info

Publication number: DK2252609T3
Authority: DK; Denmark
Prior art keywords: pyridin; derivatives; immuno modulators; immuno; modulators
Prior art date: 2008-03-07

Application number

DK09716943.7T

Other languages

English (en)

Inventor

Martin Bolli

Cyrille Lescop

Boris Mathys

Claus Mueller

Oliver Nayler

Beat Steiner

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-07

Filing date

2009-02-25

Publication date

2013-06-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40584746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2252609(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-02-25 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2013-06-24 Application granted granted Critical

2013-06-24 Publication of DK2252609T3 publication Critical patent/DK2252609T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Oncology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

DK09716943.7T 2008-03-07 2009-02-25 Pyridin-2-yl-derivater som immunomodulerende midler DK2252609T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB2008050848		2008-03-07
PCT/IB2009/050749 WO2009109872A1 (en)	2008-03-07	2009-02-25	Pyridin-2-yl derivatives as immunomodulating agents

Publications (1)

Publication Number	Publication Date
DK2252609T3 true DK2252609T3 (da)	2013-06-24

Family

ID=40584746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09716943.7T DK2252609T3 (da)	2008-03-07	2009-02-25	Pyridin-2-yl-derivater som immunomodulerende midler

Country Status (27)

Country	Link
US (1)	US8575200B2 (da)
EP (1)	EP2252609B1 (da)
JP (1)	JP5435745B2 (da)
KR (1)	KR101615779B1 (da)
CN (1)	CN102015695B (da)
AR (1)	AR070858A1 (da)
AU (1)	AU2009220861B2 (da)
BR (1)	BRPI0909055A2 (da)
CA (1)	CA2715437C (da)
CL (1)	CL2009000532A1 (da)
CY (1)	CY1114096T1 (da)
DK (1)	DK2252609T3 (da)
ES (1)	ES2414533T3 (da)
HK (1)	HK1150601A1 (da)
HR (1)	HRP20130641T1 (da)
IL (1)	IL207972A (da)
MA (1)	MA32173B1 (da)
MX (1)	MX2010009644A (da)
MY (1)	MY183039A (da)
NZ (1)	NZ588438A (da)
PL (1)	PL2252609T3 (da)
PT (1)	PT2252609E (da)
RU (1)	RU2494099C2 (da)
SI (1)	SI2252609T1 (da)
TW (1)	TWI444377B (da)
WO (1)	WO2009109872A1 (da)
ZA (1)	ZA201007136B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2447071C2 (ru) *	2006-09-07	2012-04-10	Актелион Фармасьютиклз Лтд	Производные пиридин-4-ила в качестве иммуномодулирующих агентов
PT2069335E (pt) *	2006-09-08	2013-03-04	Actelion Pharmaceuticals Ltd	Derivados de piridin-3-ilo como agentes imunomoduladores
CA2662673A1 (en) *	2006-09-21	2008-03-27	Martin Bolli	Phenyl derivatives and their use as immunomodulators
ES2450750T3 (es) *	2007-03-16	2014-03-25	Actelion Pharmaceuticals Ltd.	Derivados de amino-piridina como agonistas del receptor S1P1/EDG1
CA2695509A1 (en) *	2007-08-17	2009-02-26	Actelion Pharmaceuticals Ltd	Pyridine derivatives as s1p1/edg1 receptor modulators
KR20100092473A (ko) *	2007-11-01	2010-08-20	액테리온 파마슈티칼 리미티드	신규한 피리미딘 유도체
PT2454255E (pt)	2009-07-16	2014-01-14	Actelion Pharmaceuticals Ltd	Derivados de piridin-4-il como agonistas de s1/p1/edg1
ES2496093T3 (es) *	2010-04-15	2014-09-18	Merck Patent Gmbh	Proceso para la preparación de hidroquinonas
KR101869120B1 (ko)	2011-01-19	2018-06-19	이도르시아 파마슈티컬스 리미티드	2-메톡시-피리딘-4-일 유도체
CA2900910C (en) *	2013-03-15	2021-03-30	Actelion Pharmaceuticals Ltd	Pyridin-4-yl derivatives
TWI711609B (zh)	2015-05-20	2020-12-01	瑞士商愛杜西亞製藥有限公司	結晶形式

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3647809A (en)	1968-04-26	1972-03-07	Chinoin Gyogyszer Es Vegyeszet	Certain pyridyl-1 2 4-oxadiazole derivatives
ZA917371B (en)	1990-09-20	1992-06-24	Merrell Dow Pharma	Calcium uptake inhibitors
DE4429465A1 (de)	1994-08-19	1996-02-22	Bayer Ag	Verfahren zur Herstellung von 2-Halogenpyridinaldehyden und neue 2-Halogenpyridinaldehyde
JP2003034684A (ja) *	2001-06-29	2003-02-07	Biofor Inc	新規な種類の抗真菌剤
AU2003276043A1 (en) *	2002-06-17	2003-12-31	Merck & Co., Inc.	1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
DE10237883A1 (de)	2002-08-19	2004-03-04	Merckle Gmbh Chem.-Pharm. Fabrik	Substituierte Isoxazolderivate und ihre Verwendung in der Pharmazie
WO2004035538A1 (en) *	2002-10-15	2004-04-29	Merck & Co., Inc.	Process for making azetidine-3-carboxylic acid
WO2005032465A2 (en)	2003-10-01	2005-04-14	Merck & Co., Inc.	3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
US7605171B2 (en)	2003-12-17	2009-10-20	Merck & Co., Inc.	(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
EP1760071A4 (en) *	2004-06-23	2008-03-05	Ono Pharmaceutical Co	COMPOUND WITH S1P RECEPTOR BINDING ABILITY AND USE THEREOF
WO2006010379A1 (en)	2004-07-29	2006-02-02	Actelion Pharmaceuticals Ltd.	Novel thiophene derivatives as immunosuppressive agents
ATE541830T1 (de)	2004-12-13	2012-02-15	Ono Pharmaceutical Co	Aminocarbonsäurederivat und dessen medizinische verwendung
PL1863787T3 (pl)	2005-03-23	2011-10-31	Idorsia Pharmaceuticals Ltd	Uwodornione pochodne benzo[c]tiofenu jako immunomodulatory
PL1863474T3 (pl)	2005-03-23	2009-04-30	Actelion Pharmaceuticals Ltd	Nowe pochodne tiofenu jako agoniści receptora 1 1-fosforanu sfingozyny
EP1863475B1 (en)	2005-03-23	2011-09-07	Actelion Pharmaceuticals Ltd.	Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
WO2006108103A1 (en)	2005-04-05	2006-10-12	Pharmacopeia, Inc.	Purine and imidazopyridine derivatives for immunosuppression
DE602006015297D1 (de)	2005-04-22	2010-08-19	Daiichi Sankyo Co Ltd	3-azetidincarbonsäure-derivate zur verwendung als immunsuppressiva
CA2610310A1 (en) *	2005-06-08	2006-12-14	Novartis Ag	Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands
RU2007147940A (ru) *	2005-06-08	2009-07-20	Новартис АГ (CH)	Полициклические оксадиазолы или изоксазолы и их применение в качестве лигандов s1p рецептора
US20070043104A1 (en)	2005-06-10	2007-02-22	Luthman Ingrid K	UII-modulating compounds and their use
CN101203503B (zh)	2005-06-24	2011-12-28	埃科特莱茵药品有限公司	新颖噻吩衍生物
AR057894A1 (es)	2005-11-23	2007-12-26	Actelion Pharmaceuticals Ltd	Derivados de tiofeno
TWI404706B (zh) *	2006-01-11	2013-08-11	Actelion Pharmaceuticals Ltd	新穎噻吩衍生物
WO2007086001A2 (en)	2006-01-24	2007-08-02	Actelion Pharmaceuticals Ltd	Novel pyridine derivatives
JP4383525B2 (ja) *	2006-05-09	2009-12-16	ファイザー・プロダクツ・インク	シクロアルキルアミノ酸誘導体およびその医薬組成物
AR061841A1 (es)	2006-09-07	2008-09-24	Actelion Pharmaceuticals Ltd	Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores.
RU2447071C2 (ru) *	2006-09-07	2012-04-10	Актелион Фармасьютиклз Лтд	Производные пиридин-4-ила в качестве иммуномодулирующих агентов
PT2069335E (pt) *	2006-09-08	2013-03-04	Actelion Pharmaceuticals Ltd	Derivados de piridin-3-ilo como agentes imunomoduladores
CA2662673A1 (en) *	2006-09-21	2008-03-27	Martin Bolli	Phenyl derivatives and their use as immunomodulators
MX2009003129A (es) *	2006-09-29	2009-04-06	Novartis Ag	Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.
JP2008120794A (ja)	2006-10-16	2008-05-29	Daiichi Sankyo Co Ltd	ヘテロ環化合物を含有する医薬組成物
JP2010513283A (ja)	2006-12-15	2010-04-30	アボット・ラボラトリーズ	新規なオキサジアゾール化合物
ES2450750T3 (es) *	2007-03-16	2014-03-25	Actelion Pharmaceuticals Ltd.	Derivados de amino-piridina como agonistas del receptor S1P1/EDG1
CA2695509A1 (en)	2007-08-17	2009-02-26	Actelion Pharmaceuticals Ltd	Pyridine derivatives as s1p1/edg1 receptor modulators
KR20100092473A (ko) *	2007-11-01	2010-08-20	액테리온 파마슈티칼 리미티드	신규한 피리미딘 유도체
US8148410B2 (en)	2007-12-10	2012-04-03	Actelion Pharmaceuticals Ltd.	Thiophene derivatives as agonists of S1P1/EDG1
JP5411877B2 (ja)	2008-03-06	2014-02-12	アクテリオンファーマシューティカルズリミテッド	ピリジン化合物
CA2714614A1 (en)	2008-03-06	2009-09-11	Actelion Pharmaceuticals Ltd	Novel pyrimidine-pyridine derivatives
KR20100125380A (ko)	2008-03-07	2010-11-30	액테리온 파마슈티칼 리미티드	신규한 아미노메틸 벤젠 유도체
PT2454255E (pt)	2009-07-16	2014-01-14	Actelion Pharmaceuticals Ltd	Derivados de piridin-4-il como agonistas de s1/p1/edg1

2009
- 2009-02-25 MY MYPI2010004192A patent/MY183039A/en unknown
- 2009-02-25 US US12/920,656 patent/US8575200B2/en active Active
- 2009-02-25 JP JP2010549213A patent/JP5435745B2/ja not_active Expired - Fee Related
- 2009-02-25 PT PT97169437T patent/PT2252609E/pt unknown
- 2009-02-25 ES ES09716943T patent/ES2414533T3/es active Active
- 2009-02-25 NZ NZ588438A patent/NZ588438A/en not_active IP Right Cessation
- 2009-02-25 SI SI200930611T patent/SI2252609T1/sl unknown
- 2009-02-25 PL PL09716943T patent/PL2252609T3/pl unknown
- 2009-02-25 KR KR1020107021960A patent/KR101615779B1/ko active IP Right Grant
- 2009-02-25 BR BRPI0909055-0A patent/BRPI0909055A2/pt not_active Application Discontinuation
- 2009-02-25 WO PCT/IB2009/050749 patent/WO2009109872A1/en active Application Filing
- 2009-02-25 MX MX2010009644A patent/MX2010009644A/es active IP Right Grant
- 2009-02-25 CA CA2715437A patent/CA2715437C/en active Active
- 2009-02-25 CN CN200980108360.0A patent/CN102015695B/zh not_active Expired - Fee Related
- 2009-02-25 RU RU2010140854/04A patent/RU2494099C2/ru not_active IP Right Cessation
- 2009-02-25 EP EP09716943.7A patent/EP2252609B1/en active Active
- 2009-02-25 AU AU2009220861A patent/AU2009220861B2/en not_active Ceased
- 2009-02-25 DK DK09716943.7T patent/DK2252609T3/da active
- 2009-03-06 AR ARP090100812A patent/AR070858A1/es not_active Application Discontinuation
- 2009-03-06 CL CL2009000532A patent/CL2009000532A1/es unknown
- 2009-03-06 TW TW098107431A patent/TWI444377B/zh not_active IP Right Cessation
2010
- 2010-09-05 IL IL207972A patent/IL207972A/en not_active IP Right Cessation
- 2010-09-29 MA MA33209A patent/MA32173B1/fr unknown
- 2010-10-06 ZA ZA2010/07136A patent/ZA201007136B/en unknown
2011
- 2011-05-11 HK HK11104636.9A patent/HK1150601A1/xx not_active IP Right Cessation
2013
- 2013-07-02 CY CY20131100534T patent/CY1114096T1/el unknown
- 2013-07-08 HR HRP20130641AT patent/HRP20130641T1/hr unknown

Also Published As

Publication number	Publication date
KR20100137493A (ko)	2010-12-30
JP5435745B2 (ja)	2014-03-05
IL207972A (en)	2016-03-31
CA2715437C (en)	2016-05-24
ZA201007136B (en)	2014-03-26
AU2009220861B2 (en)	2014-05-29
IL207972A0 (en)	2010-12-30
PT2252609E (pt)	2013-06-24
TW200940532A (en)	2009-10-01
SI2252609T1 (sl)	2013-07-31
MY183039A (en)	2021-02-08
RU2494099C2 (ru)	2013-09-27
PL2252609T3 (pl)	2013-09-30
MA32173B1 (fr)	2011-03-01
CY1114096T1 (el)	2016-07-27
EP2252609A1 (en)	2010-11-24
BRPI0909055A2 (pt)	2019-02-26
AR070858A1 (es)	2010-05-12
AU2009220861A1 (en)	2009-09-11
EP2252609B1 (en)	2013-04-17
US20100331372A1 (en)	2010-12-30
CN102015695B (zh)	2014-08-27
TWI444377B (zh)	2014-07-11
US8575200B2 (en)	2013-11-05
KR101615779B1 (ko)	2016-04-26
HRP20130641T1 (en)	2013-08-31
RU2010140854A (ru)	2012-04-20
ES2414533T3 (es)	2013-07-19
NZ588438A (en)	2012-05-25
CA2715437A1 (en)	2009-09-11
CN102015695A (zh)	2011-04-13
MX2010009644A (es)	2010-09-22
JP2011513381A (ja)	2011-04-28
CL2009000532A1 (es)	2010-04-09
HK1150601A1 (en)	2012-01-06
WO2009109872A1 (en)	2009-09-11

Publication	Publication Date	Title
DK2069336T3 (da)	2013-02-25	Pyridin-4-yl-derivater som immunomodulerende midler
DK2069335T3 (da)	2013-02-18	Pyridin-3-ylderivater som immunomoduleringsmidler
DK2252609T3 (da)	2013-06-24	Pyridin-2-yl-derivater som immunomodulerende midler
DK2300465T3 (da)	2019-06-24	Imidazopyridinderivater som hæmmere af receptortyrosinkinaser
DK2144897T3 (da)	2011-02-07	8-Oxy-quinolinderivater som bradykinin B2-receptormodulatorer
DK3124483T3 (da)	2019-09-02	Pyrazolaminopyrimidin-derivater som LRRK2-modulatorer
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
DK2069324T3 (da)	2013-09-02	Fusioneret aminopyridin som hsp90-inhibitorer
DK3072906T3 (da)	2021-12-13	Antistofformulering
EP2358392A4 (en)	2012-08-29	ANTIBODY FORMULATION
DE602008002756D1 (de)	2010-11-04	Bauzusammensetzung
BRPI0914657A2 (pt)	2019-09-24	piridin-2-onae piridazin-3-onas substituídas
DK2139892T3 (da)	2011-12-12	Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer
BR112012000763A2 (pt)	2018-03-13	derivados de piridin-4-ila
BRPI0913832A2 (pt)	2015-10-20	derivados de pirrolopiridinilpirimidin-2-ilamina
DK2195311T3 (da)	2011-05-23	Pyridinderivater som S1P1/EDG1-receptormodulatorer
EP2331543A4 (en)	2013-06-19	3-deazaneplanocin DERIVATIVES
BRPI0915064A2 (pt)	2015-10-27	derivados de qunoxalinadiona
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
DK2035549T3 (da)	2014-10-13	Abcb5-positive mesenkymale stamceller som immunmodulatorer
ATE518837T1 (de)	2011-08-15	Indazolamidderivate
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
DK3070091T3 (da)	2019-07-08	Benzodioxolderivater som phosphodiesterasehæmmere
DK2513106T3 (da)	2014-01-13	Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer